Two vehicle groups, one for ointment, one for gel.
Recolonisation of the nose from staph is normal.
Possibility (low) of intermittent carriers of staph, vs permanent. The screening of 2 tests is to help eliminate/reduce that but it isn't a sure thing.
Market is missing the point of CBD being used to clear bacteria on the skin, safely. Lot of indications to be used in.
76 vs 24 is a pretty clear result, and 76% probably would be higher still if taken at the end of the 5 day period instead of measuring something that is naturally found on the body and can recolonise.
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-530
-
- There are more pages in this discussion • 471 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |